Circulating Tumor Cells Advances in Liquid Biopsy Technologies /
It is well recognized that blood could be the optimal site for evaluating cancer, allowing easy and repeated access for determining prognosis, establishing molecular targets, evaluating the efficacy of therapy, detecting the earliest signs of recurrence, and even detecting cancer at its earliest and...
Tallennettuna:
| Yhteisötekijä: | |
|---|---|
| Muut tekijät: | , |
| Aineistotyyppi: | Elektroninen E-kirja |
| Kieli: | englanti |
| Julkaistu: |
Cham :
Springer International Publishing : Imprint: Springer,
2023.
|
| Painos: | 2nd ed. 2023. |
| Sarja: | Current Cancer Research,
|
| Aiheet: | |
| Linkit: | https://doi.org/10.1007/978-3-031-22903-9 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|
Sisällysluettelo:
- Part 1. CTC Technologies
- Affinity
- Physical
- ctDNA
- miRNA
- Exosomes
- Part 2
- Biology of CTC
- Dormancy
- Culture
- EMT
- ctDNA and Exosomes
- Cells in circulation with CTC
- Part 3
- CTC Analysis
- IHC, FISH, and other molecular assays
- Functional characterization
- Advanced microscopy and AI
- Analysis of non-cellular circulating markers
- Part 4
- Clinical Applications of the Liquid Biopsy
- Early detection and cancer screening
- Prognosis and therapeutic monitoring
- Applications in Clinical Trials
- Applications in Drug Development.